WNK2 and glaucoma: Diah et al. indicated that the ROCK inhibitor Y‐27,632 may inhibit fibrosis and improve outcomes after glaucoma filtration surgery by inhibiting the transdifferentiation of Tenon fibroblasts into myofibroblasts and the transforming growth factor-β and mitogen-activated protein kinase signaling after surgery [19].